Literature DB >> 22160668

New automated Markov-Gibbs random field based framework for myocardial wall viability quantification on agent enhanced cardiac magnetic resonance images.

Ahmed Elnakib1, Garth M Beache, Georgy Gimel'farb, Ayman El-Baz.   

Abstract

A novel automated framework for detecting and quantifying viability from agent enhanced cardiac magnetic resonance images is proposed. The framework identifies the pathological tissues based on a joint Markov-Gibbs random field (MGRF) model that accounts for the 1st-order visual appearance of the myocardial wall (in terms of the pixel-wise intensities) and the 2nd-order spatial interactions between pixels. The pathological tissue is quantified based on two metrics: the percentage area in each segment with respect to the total area of the segment, and the trans-wall extent of the pathological tissue. This transmural extent is estimated using point-to-point correspondences based on a Laplace partial differential equation. Transmural extent was validated using a simulated phantom. We tested the proposed framework on 14 datasets (168 images) and validated against manual expert delineation of the pathological tissue by two observers. Mean Dice similarity coefficients (DSC) of 0.90 and 0.88 were obtained for the observers, approaching the ideal value, 1. The Bland-Altman statistic of infarct volumes estimated by manual versus the MGRF estimation revealed little bias difference, and most values fell within the 95% confidence interval, suggesting very good agreement. Using the DSC measure we documented statistically significant superior segmentation performance for our MGRF method versus established intensity-based methods (greater DSC, and smaller standard deviation). Our Laplace method showed good operating characteristics across the full range of extent of transmural infarct, outperforming conventional methods. Phantom validation and experiments on patient data confirmed the robustness and accuracy of the proposed framework.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22160668     DOI: 10.1007/s10554-011-9991-2

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  29 in total

1.  Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography.

Authors:  Christoph Klein; Stephan G Nekolla; Frank M Bengel; Mitsuru Momose; Andrea Sammer; Felix Haas; Bernhard Schnackenburg; Wolfram Delius; Harald Mudra; Dieter Wolfram; Markus Schwaiger
Journal:  Circulation       Date:  2002-01-15       Impact factor: 29.690

Review 2.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

3.  A novel 3D joint Markov-Gibbs model for extracting blood vessels from PC-MRA images.

Authors:  Ayman El-Baz; Georgy Gimel'farb; Robert Falk; Mohamed Abou El-Ghar; Vedant Kumar; David Heredia
Journal:  Med Image Comput Comput Assist Interv       Date:  2009

4.  Modification of the centerline method for assessment of echocardiographic wall thickening and motion: a comparison with areas of risk.

Authors:  M J McGillem; G B Mancini; S F DeBoe; A J Buda
Journal:  J Am Coll Cardiol       Date:  1988-04       Impact factor: 24.094

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

7.  Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model.

Authors:  Luciano C Amado; Bernhard L Gerber; Sandeep N Gupta; Dan W Rettmann; Gilberto Szarf; Robert Schock; Khurram Nasir; Dara L Kraitchman; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2004-12-21       Impact factor: 24.094

8.  Semi-automatic quantification of myocardial infarction from delayed contrast enhanced magnetic resonance imaging.

Authors:  Einar Heiberg; Henrik Engblom; Jan Engvall; Erik Hedström; Martin Ugander; Håkan Arheden
Journal:  Scand Cardiovasc J       Date:  2005-10       Impact factor: 1.589

9.  Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction.

Authors:  Bernhard L Gerber; Jérôme Garot; David A Bluemke; Kathérine C Wu; João A C Lima
Journal:  Circulation       Date:  2002-08-27       Impact factor: 29.690

10.  Quantification of late gadolinium enhanced CMR in viability assessment in chronic ischemic heart disease: a comparison to functional outcome.

Authors:  Aernout M Beek; Olga Bondarenko; Farshid Afsharzada; Albert C van Rossum
Journal:  J Cardiovasc Magn Reson       Date:  2009-03-09       Impact factor: 5.364

View more
  2 in total

1.  Intramyocardial strain estimation from cardiac cine MRI.

Authors:  Ahmed Elnakib; Garth M Beache; Georgy Gimel'farb; Ayman El-Baz
Journal:  Int J Comput Assist Radiol Surg       Date:  2014-12-27       Impact factor: 2.924

Review 2.  Cardiovascular imaging 2012 in the International Journal of Cardiovascular Imaging.

Authors:  Hiram G Bezerra; Ricardo A Costa; Johan H C Reiber; Frank J Rybicki; Paul Schoenhagen; Arthur A Stillman; Johan De Sutter; Nico R L Van de Veire; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2013-04       Impact factor: 2.357

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.